TotalMarketCap

Bright Minds Biosciences

DRUGNasdaq CanadaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$201.301 M

$20.50 +8.12%

Close of 6 Nov 2026

As of 6 Nov 2026, Bright Minds Biosciences (DRUG) has a market capitalization of $201.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #245Sol-Gel TechnologiesSLGL$206.3M
  2. #246Cartesian TherapeuticsRNAC$205.2M
  3. #247Bright Minds BiosciencesDRUG$201.3M
  4. #248Eledon PharmaceuticalsELDN$199.9M
  5. #249InflaRxIFRX$198.9M

What if Bright Minds Biosciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,875,574

Per share 140,272× higher

Bitcoin $1.53T

$155,592.30

Per share 7,590× higher

Apple $5.02T

$510,794.99

Per share 24,917× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Bright Minds Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.